Wang, M. L., Jurczak, W., Zinzani, P. L., Eyre, T. A., Cheah, C. Y., Ujjani, C. S., Koh, Y., Izutsu, K., Gerson, J. N., Flinn, I., Tessoulin, B., Alencar, A. J., Ma, S., Lewis, D., Lech-Maranda, E., Rhodes, J., Patel, K., Maddocks, K., Lamanna, N., … Shah, N. N. (2023). Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell Lymphoma. Journal of Clinical Oncology, 41(24), 3988–3997. https://doi.org/10.1200/jco.23.00562
Subjects:
Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia
(OpenAlex Topic)
Lymphoid Neoplasms
(OpenAlex Topic)
Diagnosis and Treatment of Primary Central Nervous System Lymphoma
(OpenAlex Topic)
Lymphoma, Mantle-Cell
(MeSH)
Publication Type:
Article
Unique ID:
10.1200/jco.23.00562
PMID:
DOI:
Journal:
Publication Date:
Data Source:
OpenAlex
Source Link: